e-learning
resources
Munich 2006
Tuesday 05.09.2006
Recent advances in the treatment of asthma and allergic rhinitis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma
K. F. Rabe, T. Atienza, P. Magyar, P. Larsson, C. Jorup, U. G. Lalloo (Leiden, Netherlands; Quezon City, Philippines; Budapest, Hungary; Lund, Sweden; Durban, South Africa)
Source:
Annual Congress 2006 - Recent advances in the treatment of asthma and allergic rhinitis
Session:
Recent advances in the treatment of asthma and allergic rhinitis
Session type:
Thematic Poster Session
Number:
3866
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. F. Rabe, T. Atienza, P. Magyar, P. Larsson, C. Jorup, U. G. Lalloo (Leiden, Netherlands; Quezon City, Philippines; Budapest, Hungary; Lund, Sweden; Durban, South Africa). A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma. Eur Respir J 2006; 28: Suppl. 50, 3866
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
What is the role of oral corticosteroids in the era of biologics in asthma?
Source: International Congress 2019 – State of the art session: Airway disease
Year: 2019
Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment
Source: Eur Respir J 2008; 31: 1145-1147
Year: 2008
Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
Year: 2005
Is there a problem with oral corticosteroid use in asthma?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
How effective are oral steroids in asthma action plans?
Source: International Congress 2017 – Asthma management
Year: 2017
The development of an algorithm for the rational use of intravenous salbutamol in severe paediatric asthma
Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives
Year: 2008
Single inhaler therapy with budesonide/formoterol in an allergic rat model: a new therapeutic strategy in asthma
Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids
Year: 2004
Proof of concept study to evaluate step down therapy with inhaled corticosteroid alone or additive therapy on surrogate inflammatory markers in asthma
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
Pharmacological characterization of CHF6162, a novel long acting inhaled corticosteroid for the treatment of asthma
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017
Budesonide/formoterol for maintenance and as needed — a new approach to asthma management in children
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005
The concept study: comparative influence of two treatment strategies on airway response to AMP
Source: Annual Congress 2005 - Combination therapy for asthma. Which, why and how?
Year: 2005
High or standard initial dose of budesonide to control mild-to-moderate asthma?
Source: Eur Respir J 2001; 17: 856-862
Year: 2001
The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
Emerging biologic approaches for the treatment of difficult to control asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017
Suppression of
F
ENO
with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Year: 2019
Once per day inhaled corticosteroids: a method to improve compliance and asthma control
Source: Eur Respir J 2001; 18: Suppl. 33, 441s
Year: 2001
Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept